We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information to support your recovery after COVID-19.
Information about how the Competition and Markets Authority responded to the coronavirus (COVID-19) outbreak.
All data on external disclosures made to the CMA
Letters sent by the Competition and Markets Authority (CMA) to companies about their non-compliance with market investigation orders and undertakings.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Information on procedures, potential consequences of non-notification, new and adopted CMA guidance and who to contact.
The CMA is reviewing Part 3, Article 29, and Part 1 of Schedule 4 of the Home Credit Market Investigation Order 2007
Information about what to do if you receive a warning or advisory letter from the CMA.
These are the minutes of the CMA's September 2014 board meeting.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
Laboratories can use these templates to notify relevant clinicians of a presumed positive blood spot screening result for cystic fibrosis (CF).
These are the minutes of the CMA's December 2014 board meeting.
The CMA is investigating the anticipated acquisition by Cochlear Limited of the hearing implants business of Demant A/S, known as Oticon Medical.
You can appeal a Motorcycle Single Vehicle Approval (MSVA) inspection failure decision if you think it's wrong.
Business expenses of the CMA board for April to June 2016.
The CMA has today appointed its new General Counsel and Executive Director for Digital Markets.
The CMA has today published its main concerns following an initial review into the veterinary sector.
After extensive engagement, the CMA has published its Annual Plan for 2024 to 2025.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.